Connect with us

Hi, what are you looking for?

Jewish Business News

The A-List

$8B drug deal is big winner for Bonderman

David Bonderman

Endo International announced on Monday that it was buying Par Pharmaceutical from Bonderman’s TPG Capital for $8.1 billion.

The deal gives TPG and co-investors a profit of $6 billion — after paying off $2.3 billion of debt — giving it a return of better than seven-fold on a roughly $850 million investment just three years ago…


By Josh Kosman



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The Movie The Professional is what made Natalie Portman a Lolita.


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.